Tags: Cancer | melanoma | skin | cancer | Cobimetinib | Zelboraf

New Drug Extends Lives of Skin Cancer Patients

Monday, 14 Jul 2014 12:55 PM

 


An experimental drug from Roche helped people with an advanced form of skin cancer live longer without their disease worsening when used in combination with another treatment, the Swiss drugmaker said on Monday.
 
Pharmaceutical companies are looking to combination therapy to yield better results and drug cocktails are expected to be crucial as oncologists seek to block cancer on multiple fronts.
 
Cobimetinib, which is being developed in collaboration with Exelixis Inc, is designed to be used with another Roche drug called Zelboraf for patients with tumors that have a mutation in a gene known as BRAF that allows melanoma cells to grow.
 
About half of all melanomas have the genetic aberration the drugs target.
 
Results of a Phase III study involving 495 patients previously untreated for advanced melanoma found those taking both drugs lived significantly longer without their disease worsening compared to those taking Zelboraf alone.
 
Roche plans to present the results at an upcoming medical meeting and said it would file the data for approval with health regulators worldwide
.
Melanoma globally afflicts more than 232,000 new people each year. While generally curable if caught early, it is one of the deadliest cancers in its advanced stages and there are few treatment options.
 
Cobimetinib works by blocking the activity of a protein called MEK, while Zelboraf - which is already approved in more than 80 countries - binds to the mutant protein BRAF.
 
Roche is also investigating cobimetinib in combination with other experimental medicines, including an immunotherapy for the treatment of non-small cell lung cancer and colorectal cancer.
 

© 2015 Thomson/Reuters. All rights reserved.

Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Top Trainer's Step-by-Step Plan for Better Fitness

Sunday, 25 Jan 2015 11:25 AM

The excitement and anticipation surrounding the upcoming Super Bowl may prompt some people to take up anew sport or up t . . .

Tide Turning in Ebola Fight After Hard Lessons

Saturday, 24 Jan 2015 15:16 PM

A top U.N. official in the fight against Ebola greeted just three patients at one treatment center he visited this week  . . .

'Miracle' Vaccine, Drugs Will Soon Stop AIDS: Bill Gates

Saturday, 24 Jan 2015 10:18 AM

Two new tools to fight AIDS should be available by 2030 in the form of a vaccine and new intense drug treatments, ending . . .

Most Commented

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved